World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
56
Citations
13293
World Ranking
3697
National Ranking
256

Best Publications

  • Long-term survival and late deaths after allogeneic bone marrow transplantation. Late Effects Working Committee of the International Bone Marrow Transplant Registry.

    G Socié;J V Stone;J R Wingard;D Weisdorf

  • Standard graft-versus-host disease prophylaxis with or without anti-T-cell globulin in haematopoietic cell transplantation from matched unrelated donors: a randomised, open-label, multicentre phase 3 trial

    Jürgen Finke;Wolfgang A Bethge;Claudia Schmoor;Hellmut D Ottinger

  • Graft-versus-leukemia effects of transplantation and donor lymphocytes

    Hans-Jochem Kolb

  • Sequential Regimen of Chemotherapy, Reduced-Intensity Conditioning for Allogeneic Stem-Cell Transplantation, and Prophylactic Donor Lymphocyte Transfusion in High-Risk Acute Myeloid Leukemia and Myelodysplastic Syndrome

    Christoph Schmid;Michael Schleuning;Georg Ledderose;Johanna Tischer

  • Graft-versus-leukemia reactions in allogeneic chimeras

    Hans-Jochem Kolb;Hans-Jochem Kolb;Christoph Schmid;Christoph Schmid;A. John Barrett;A. John Barrett;Dolores J. Schendel;Dolores J. Schendel

  • Chronic graft-versus-host disease: long-term results from a randomized trial on graft-versus-host disease prophylaxis with or without anti-T-cell globulin ATG-Fresenius.

    Gérard Socié;Claudia Schmoor;Wolfgang A. Bethge;Hellmut D. Ottinger

  • Assessment of imatinib as first-line treatment of chronic myeloid leukemia: 10-year survival results of the randomized CML study IV and impact of non-CML determinants

    Rüdiger Hehlmann;Michael Lauseker;Susanne Saußele;Markus Pfirrmann

  • The t(8;9)(p22;p24) is a recurrent abnormality in chronic and acute leukemia that fuses PCM1 to JAK2

    Andreas Reiter;Christoph Walz;Ann Watmore;Claudia Schoch

  • Effective and long-term control of EBV PTLD after transfer of peptide-selected T cells

    Andreas Moosmann;Iris Bigalke;Johanna Tischer;Leah Schirrmann

  • Allogeneic hematopoietic stem cell transplantation (allo SCT) for chronic myeloid leukemia in the imatinib era : evaluation of its impact within a subgroup of the randomized German CML Study IV

    Susanne Saussele;Michael Lauseker;Alois Gratwohl;Dietrich W. Beelen

  • Proteomics applied to the clinical follow up of patients after allogeneic hematopoietic stem cell transplantation

    Thorsten Kaiser;Haytham Kamal;Andreas Rank;Hans-Jochem Kolb

  • Prospective evaluation of neurological complications after allogeneic bone marrow transplantation

    P. Sostak;C.S. Padovan;T.A. Yousry;G. Ledderose

  • Long-term results after allogeneic bone marrow transplantation for chronic myelogenous leukemia in chronic phase: a report from the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation

    F van Rhee;R M Szydlo;J Hermans;A Devergie

  • High-Dose Therapy and Autologous Stem-Cell Transplantation in Angioimmunoblastic Lymphoma: Complete Remission at Transplantation Is the Major Determinant of Outcome—Lymphoma Working Party of the European Group for Blood and Marrow Transplantation

    Charalampia Kyriakou;Carmen Canals;Anthony Goldstone;Dolores Caballero

  • Evidence of peripheral blood-derived, plastic-adherent CD34(-/low) hematopoietic stem cell clones with mesenchymal stem cell characteristics.

    Ralf Huss;Claudia Lange;Eva M. Weissinger;Hans-Jochem Kolb

  • Second Allograft for Hematologic Relapse of Acute Leukemia After First Allogeneic Stem-Cell Transplantation From Related and Unrelated Donors: The Role of Donor Change

    Maximilian Christopeit;Oliver Kuss;Jürgen Finke;Ulrike Bacher

  • Adoptive immunotherapy with donor lymphocyte transfusions.

    Hans-Jochem Kolb;Ernst Holler

  • Impact of human herpesvirus-6 after haematopoietic stem cell transplantation.

    Marcus Hentrich;Daniel Oruzio;Gundula Jäger;Marcus Schlemmer

  • Plasminogen activator inhibitor-1 confirms the diagnosis of hepatic veno-occlusive disease in patients with hyperbilirubinemia after bone marrow transplantation

    Christoph Salat;Ernst Holler;Hans-Jochem Kolb;Brigitte Reinhardt

  • Secondary leukaemia and myelodysplasia after autografting for lymphoma: results from the EBMT

    D W Milligan;M C Ruiz De Elvira;H J Kolb;A H Goldstone

Frequent Co-Authors

Christoph Schmid
Christoph Schmid University of Augsburg
Ernst Holler
Ernst Holler University of Regensburg
Andreas Hochhaus
Andreas Hochhaus Friedrich Schiller University Jena
Rüdiger Hehlmann
Rüdiger Hehlmann Heidelberg University
Alois Gratwohl
Alois Gratwohl University of Basel
Claudia Haferlach
Claudia Haferlach Ludwig-Maximilians-Universität München
Axel R. Zander
Axel R. Zander Huntsman Cancer Institute
Susanne Schnittger
Susanne Schnittger Ludwig-Maximilians-Universität München
Lothar Kanz
Lothar Kanz University of Tübingen
Arnold Ganser
Arnold Ganser Hannover Medical School

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Best Scientists Citing Hans-Jochem Kolb

Recently Published Articles